Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LYMPHOCYTES for Malignant melanoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where LYMPHOCYTES was used for Malignant melanoma.

Most Reported Side Effects for LYMPHOCYTES

Side Effect Reports % Deaths Hosp.
Drug ineffective 12 24.5% 0 3
Disease progression 7 14.3% 1 2
Pneumonia 7 14.3% 3 1
Acute graft versus host disease 6 12.2% 0 0
Hypertension 6 12.2% 0 1
Sepsis 6 12.2% 1 1
Bacterial infection 5 10.2% 0 0
Chronic graft versus host disease 5 10.2% 0 0
Dry eye 5 10.2% 0 0
Dysphagia 5 10.2% 0 0
Extremity contracture 5 10.2% 0 0
Eye irritation 5 10.2% 0 0
Pain 5 10.2% 0 0
Quality of life decreased 5 10.2% 0 0

Other Indications for LYMPHOCYTES

Acute myeloid leukaemia (7) Graft versus host disease (5) Myelodysplastic syndrome (5)

Other Drugs Used for Malignant melanoma

NIVOLUMAB (10,599) IPILIMUMAB (8,903) DABRAFENIB (5,277) TRAMETINIB DIMETHYL SULFOXIDE (3,841) PEMBROLIZUMAB (3,261) BINIMETINIB (2,613) ENCORAFENIB (2,591) VEMURAFENIB (2,548) TRAMETINIB (1,448) COBIMETINIB (1,324)

Related Pages

LYMPHOCYTES Full Profile All Malignant melanoma Drugs LYMPHOCYTES Demographics LYMPHOCYTES Timeline